compound 25 [Zhang et al., 2020]   Click here for help

GtoPdb Ligand ID: 10643

Synonyms: example 6B [WO2014028600A2] [1]
PDB Ligand Immunopharmacology Ligand
Compound class: Synthetic organic
Comment: Compound 25 is an allosteric inhibitor of RORγt [2]. Its pharmacokinetic profile makes it suitable for oral administration. The chemical structure and its use are claimed in Merck's patent WO2014028600A2 [1].
Click here for help
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 2
Rotatable bonds 5
Topological polar surface area 95.66
Molecular weight 457.12
XLogP 5.25
No. Lipinski's rules broken 1
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES OC(=O)[C@@H]1CCN(C[C@H]1O)c1nn(c2c1c(F)ccc2)C(=O)c1c(Cl)cccc1C1CC1
Isomeric SMILES OC(=O)[C@@H]1CCN(C[C@H]1O)c1nn(c2c1c(F)ccc2)C(=O)c1c(Cl)cccc1C1CC1
InChI InChI=1S/C23H21ClFN3O4/c24-15-4-1-3-13(12-7-8-12)19(15)22(30)28-17-6-2-5-16(25)20(17)21(26-28)27-10-9-14(23(31)32)18(29)11-27/h1-6,12,14,18,29H,7-11H2,(H,31,32)/t14-,18-/m1/s1
InChI Key IBIKHMZPHNKTHM-RDTXWAMCSA-N
References
1. Barr KJ, Maclean J, Zhang H, Beresis RT. (2014)
3-AMINOCYCLOALKYL COMPOUNDS AS RORgammaT INHIBITORS AND USES THEREOF.
Patent number: WO2014028600A2. Assignee: Merck Sharp & Dohme Corp.. Priority date: 15/08/2012. Publication date: 20/02/2014.
2. Zhang H, Lapointe BT, Anthony N, Azevedo R, Cals J, Correll CC, Daniels M, Deshmukh S, van Eenenaam H, Ferguson H et al.. (2020)
Discovery of N-(Indazol-3-yl)piperidine-4-carboxylic Acids as RORγt Allosteric Inhibitors for Autoimmune Diseases.
ACS Med Chem Lett, 11 (2): 114-119. DOI: 10.1021/acsmedchemlett.9b00431 [PMID:32071676]